CompoAtlas

Betica SRIMMORE Softgel

Betica SRIMMORE Softgel : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

The foreign register category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

No point flagged by the rules applied to recognised ingredients.

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredientPublished text and quantityIdentified nutrient or substance
Coffea arabicaCoffea arabica[47 mg,1387.38 mg]Not identified
Irvingia gabonensisIrvingia gabonensis[20 mg,1387.38 mg]Not identified
Silybum marianumSilybum marianum[30 mg,1387.38 mg]Not identified
Paullinia cupanaPaullinia cupana[195 mg,1387.38 mg]Not identified
Garcinia cambogiaGarcinia cambogia[75 mg,1387.38 mg]Not identified

The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.

Product record

Registration number
MAL18016106TE
Type
Natural product
Published status
PRODUCT APPROVED
Licence holder
LONNIX (M) SDN. BHD.
Manufacturer
LONNIX (M) SDN. BHD.
Registration period starting
2023-01-18
Published validity end
2028-01-18

Original register data

View published fields and their variants
Active ingredients
Coffea arabica[47 mg,1387.38 mg],Irvingia gabonensis[20 mg,1387.38 mg],Silybum marianum[30 mg,1387.38 mg],Paullinia cupana[195 mg,1387.38 mg],Garcinia cambogia[75 mg,1387.38 mg]
Valid until
2028-01-18
Registration date
2023-01-18
Published description
NATURAL PRODUCT
Licence holder
LONNIX (M) SDN. BHD.
Producer
LONNIX (M) SDN. BHD.
Published name
Betica SRIMMORE Softgel
Published reference
17090007TE
Registration number
MAL18016106TE
Published status
PRODUCT APPROVED

Official source

View the official register, number MAL18016106TE

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Coffea arabica
    Read the warning, when it applies and the studies cited

    GREEN COFFEE BEAN EXTRACT

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding.

    Contraindications

    Do not use if you are pregnant.

    Health Canada monograph dated 31 October 2025

  • Irvingia gabonensis
    Read the warning, when it applies and the studies cited

    AFRICAN WILD MANGO - IRVINGIA GABONENSIS

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Ross 2011; Ngondi et al. 2009; Adamson et al. 1986).

    Sources cited by Health Canada (3)
    • Adamson I, Okafor C, Abu-Bakare A. Erythrocyte membrane ATPases in diabetes: effect of dikanut (Irvingia gabonensis). Enzyme 1986; 36(3): 212-215. PubMed
    • Ngondi JL, Etoundi BC, Nyangono CB, Mbofung CM, Oben JE. IGOB131, a novel seed extract of the West African plant Irvingia gabonensis, significantly reduces body weight and improves metabolic parameters in overweight humans in a randomized double-blind placebo controlled investigation. Lipids in Health and Disease 2009; 8:7. PubMed Randomised trial
    • Ross MS. A proprietary seed extract of Irvingia gabonensis is found to be effective in reducing body weight and improving metabolic parameters in overweight humans. Holistic Nursery Practice 2011; 235(4): 215-217.

    Condition of application: Antioxidant, cholesterol, glucose.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant.

    Contraindications

    Condition of application: Weight management.

    Do not use if you are pregnant.

    Known adverse reactions

    Stop use if you experience symptoms of hypoglycaemia including feelings of anxiety, dizziness, tremor, sweating, nausea or headache (Adamson et al. 1986; Ngondi et al. 2009; Oben et al. 2008a,b).

    Sources cited by Health Canada (3)
    • Adamson I, Okafor C, Abu-Bakare A. Erythrocyte membrane ATPases in diabetes: effect of dikanut (Irvingia gabonensis). Enzyme 1986; 36(3): 212-215. PubMed
    • Ngondi JL, Etoundi BC, Nyangono CB, Mbofung CM, Oben JE. IGOB131, a novel seed extract of the West African plant Irvingia gabonensis, significantly reduces body weight and improves metabolic parameters in overweight humans in a randomized double-blind placebo controlled investigation. Lipids in Health and Disease 2009; 8:7. PubMed Randomised trial
    • Oben JE, Ngondi JL, Blum K. Inhibition of Irvingina gabonensis seed extract (OB131) on adipogenesis as mediated via down regulation of the PPARgamma and leptin genes and up- regulation of the adiponectin gene. Lipids in Health and Disease 2008a; 7:44. PubMed

    Health Canada monograph dated 29 August 2025

  • Silybum marianum
    Read the warning, when it applies and the studies cited

    MILK THISTLE - SILYBUM MARIANUM

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant (Brinker 2010; Mills et al. 2006).

    Sources cited by Health Canada (2)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Mills E, Dugoua J, Perri D, Koren G. Herbal Medicines in Pregnancy and Lactation : An Evidence-Based Approach. London (UK): Taylor and Francis Medical; 2006.

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (Geier et al. 1990; Mironets et al. 1990).

    Sources cited by Health Canada (2)
    • Geier J, Fuchs Th, Wahl R. [Anaphylactic shock due to an extract of Silybum marianum in a patient with immediate-type allergy to Kiwi fruit]. Anaphylaktischer Schock durch einen Mariendistel-Extrakt bei Soforttyp-Allergie auf Kiwi. Allergologie 1990;13(10):387-388 (in German).
    • Mironets VI, Krasovskaia EA, Polischuk II. [A case of urticaria during carsil treatment]. Vrachebnoe Delo 1990;(7):86-87 (in Russian).

    Health Canada monograph dated 26 June 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Betica SRIMMORE Softgel”, https://compoatlas.com/en/supplements/malaysia/MAL18016106TE-betica-srimmore-softgel, updated 27 October 2026.

Enter to analyse, Shift+Enter for a new line